A multiple myeloma blood cancer registry, the first of its kind in Australia and New Zealand, is being piloted through the Alfred in conjunction with Monash University. Professor Andrew Spencer, Head of the ACBD Myeloma research group investigating malignant haematology and and stem cell transplantation, said that the registry was developed after a realisation that there were no correct data on myeloma in Australia,which has meant to date that there is substantial variation in therapy given to myeloma patients. The registry will give a picture of patterns of care and their outcomes.
No comments:
Post a Comment
Thankyou for your comment. We moderate all messages and may take a little time to review your comment. Please email inquiries to ccs.comms@monash.edu.